ecrin-mdr-crcClinical2011AdenocarcinomaSolid tumorPrimary Lymphoma of the Central Nervous SystemColorectal Adenocarcinoma, Non-small Cell Lung Cancer)Leukemia, LymphoidCarcinoma, Non-Small-Cell LungLymphoma, Mantle-CellMarginal Zone B Cell Lymphoma)MelanomaCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaAny T-cell MalignancyLymphomaLymphoma, B-CellNeoplasmsLeukemia, Lymphocytic, Chronic, B-CellOvarian cancerChronic Lymphocytic LeukemiaNon-small cell lung cancerBurkett's LymphomaMantle Cell LymphomaOvarian NeoplasmsSolid Tumors (Metastatic Melanoma, Renal (Clear) Cell CarcinomaLymphoma, B-Cell, Marginal ZoneHormone-refractory Prostate Adenocarcinoma, Ovarian CancerAdenocarcinomaSolid TumorColorectal Adenocarcinoma, Non-small Cell Lung Cancer)Leukemia, LymphoidMarginal Zone B Cell Lymphoma)MelanomaLymphoma, B-cell, Marginal ZoneAny T-cell MalignancyPrimary Lymphoma Of The Central Nervous SystemLymphomaCd27 Expressing B-cell Malignancies For Example Hodgkin's LymphomaNeoplasmsSolid Tumors (metastatic Melanoma, Renal (clear) Cell CarcinomaOvarian CancerChronic Lymphocytic LeukemiaBurkett's LymphomaMantle Cell LymphomaNon-small Cell Lung CancerLymphoma, Mantle-cellCarcinoma, Non-small-cell LungOvarian NeoplasmsLymphoma, B-cellLeukemia, Lymphocytic, Chronic, B-cellHormone-refractory Prostate Adenocarcinoma, Ovarian CancerInterventionalhttps://newmdr.ecrin.org/Study/2114787United States10Renal (clear) cell carcinomaMetastatic melanomaCD27 expressing Solid TumorsBurkett’s lymphomaCD27 expressing Hematologic MalignanciesColorectal adenocarcinomaHormone-refractory prostate adenocarcinomaAntibodies, MonoclonalMarginal zone B cell lymphomaECRIN MDRCompletedfalseA Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersThis is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects. The study enrolls patients with hematologic cancers (certain leukemias and lymphomas), as well as patients with select types of solid tumors.2011-10-152114787NCT01460134